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Abstract Pro-apoptotic members of the Bcl-2 family can be
subdivided in two classes according to their structure: a group
including Bax, Bak, and Bok that display Bcl-2 homology (BH)
1, BH2 and BH3 domains and a second group including Bid
(BH3 interacting domain death agonist), Bad, Bim (Bcl-2 inter-
acting mediator of cell death) and several others that contain
only a BH3 domain, the BH3-only proteins. The BH3-only
proteins have been proposed to activate pro-apoptotic members
of the Bax subfamily to trigger a mitochondrial pathway that
leads to the release of cytochrome c and other apoptogenic
factors. Here we report that the mechanism of action of Bim
is di¡erent from that of Bid. Although overexpression of Bid or
Bim in cells leads to cytochrome c release, only Bid is able to
trigger the release of cytochrome c through Bax activation when
added directly to isolated mitochondria. BimL, although unable
to activate Bax, can directly inhibit Bcl-2 or Bcl-xL. Our data
suggest two functional classes of BH3-only proteins: those such
as Bid which directly activate Bax-like proteins leading to mi-
tochondrial membrane permeability and apoptosis and those
such as Bim which inhibit anti-apoptotic proteins and render
the cells more susceptible to apoptogenic stimuli. ) 2002 Fed-
eration of European Biochemical Societies. Published by Else-
vier Science B.V. All rights reserved.
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1. Introduction
In many apoptotic responses, mitochondria play a major
role in coordinating caspase activation through the release
of apoptogenic factors, such as cytochrome c, Smac/DIABLO,
AIF (apoptosis-inducing factor) (for review, see [1]), endonu-
clease G [2] and HtrA2 [3]. Release of these proteins is con-
trolled by members of the Bcl-2 family. The anti-apoptotic
members of the Bcl-2 family, such as Bcl-2 or Bcl-xL, inhibit
the e¥ux of these proteins whereas the pro-apoptotic mem-
bers, Bax or Bak, trigger their release. The activity of these
proteins appears to be controlled by a class of proteins called
Bcl-2 homology (BH) 3-only proteins because they only dis-
play one of the three or four domains contained in either Bcl-
2/Bcl-xL or Bax and Bak. The BH3-only subfamily presently
includes mammalian Bid (BH3 interacting domain death ago-
nist), Bad, Bik/Nbk, Hrk/DP5, Bim (Bcl-2 interacting media-
tor of cell death), Bmf, Blk, Noxa, Puma and Caenorhabditis
elegans EGL-1 [4^6]. Di¡erent groups have recently demon-
strated that at least some of the BH3-only proteins undergo
post-translational modi¢cations, which determine their active
conformation following death signals (for review [7]). For
example, Bid has been shown to undergo cleavage by cas-
pase-8 and myristoylation during Fas-mediated apoptosis.
These structural changes allow cleaved Bid (tBid) to trans-
locate to mitochondria, to induce insertion and oligomeriza-
tion of Bax and/or Bak into the outer mitochondrial mem-
brane (OMM), and trigger the release of cytochrome c [8^12].
Phosphorylation of Bid by casein kinases I and II was found
to regulate its cleavage by caspase-8 [13]. In many cell types,
Bad is normally phosphorylated and, as such, interacts with
14-3-3 sca¡old proteins. During apoptosis, Bad is dephos-
phorylated and interacts with Bcl-2 or Bcl-xL, thereby inhib-
iting the anti-apoptotic activity of these proteins [14^16].
Alternative splicing generates three isoforms of Bim: BimS,
BimL, and BimEL [17]. All three isoforms are potent inducers
of apoptosis, BimS being considerably more cytotoxic than
BimL or BimEL. The additional regions present in the longer
isoforms (BimL and BimEL) attenuate its activity, by allowing
Bim to be sequestered to the microtubule-associated dynein
motor complex through binding to dynein light chain LC8/
DLC1 [18]. Upon receipt of damage signals, Bim is released
(together with LC8/DLC1) to activate the cell death machin-
ery. In addition to the post-translational control, Bim may
also be transcriptionally regulated in response to signaling
by growth factors in some cell types [19^21]. Gene targeting
in mice revealed that Bim is required for hematopoietic ho-
meostasis and its de¢ciency causes a systemic lupus erythema-
tosus-like autoimmune disease. Bim3=3 lymphocytes are resis-
tant to apoptotic stimuli such as cytokine deprivation, calcium
£ux or microtubule perturbation [22].
In this report, we have compared the molecular mechanisms
whereby tBid and Bim trigger apoptosis. Although overex-
pression of both proteins triggers apoptosis in HeLa cells,
only tBid activates Bax and triggers cytochrome c release
from isolated mitochondria. Bim appears to act through inhi-
bition of Bcl-2 or Bcl-xL.
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2. Materials and methods
2.1. Materials
Mouse monoclonal anti-Bax antibodies were purchased from Alexis
(Alexis Corporation). Goat anti-Bim monoclonal antibodies were
from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Mouse
monoclonal anti-Flag M2 antibodies were purchased from Sigma.
Mouse monoclonal antibodies against mitochondrial heat shock pro-
tein 70 (mt-hsp-70) were purchased from ABR (Laufel¢ngen, Switzer-
land) and monoclonal anti-COX antibodies were from Molecular
Probes (Eugene, OR, USA). Antigen^antibody complexes were de-
tected by using horseradish peroxidase-conjugated goat anti-rabbit
immunoglobulin G and enhanced chemiluminescence detection re-
agents (ECL system: Amersham Pharmacia Biotech).
2.2. Immunochemistry
For immunochemistry analysis, cells were seeded onto glass cover-
slips. HeLa cells were cultured in the presence or absence of 100 WM
Z-Val-Ala-Asp(OMe)-CH2F (Z-VAD-fmk). Cells were ¢xed with 4%
paraformaldehyde in phosphate-bu¡ered saline (PBS) for 10 min and
permeabilized with 0.5% Triton X-100 in PBS at room temperature
for 15 min. After washing, the cells were incubated for 1 h with anti-
Bim polyclonal antibodies, anti-Bax polyclonal antibodies, anti-cyto-
chrome c monoclonal antiboby, anti-mt-hsp-70, all diluted in
PBS+5% normal goat serum, washed twice in PBS, and developed
with £uorescein and Texas red-labeled goat anti-rabbit and goat
anti-mouse antibodies, respectively. In the last wash, 1 Wg/ml of
Hoechst 33258 was added to the cells. Coverslips were placed on a
glass slide in Vectashield mounting medium (Vector) and observed by
conventional £uorescence microscopy.
2.3. Recombinant proteins
Recombinant truncated Bid (mouse Bid residues 60^195) (rtBid)
with a tag of six histidines at the N terminus, His-tagged human
Bcl-xL (rBcl-xL) and human Bcl-2 both lacking the C-terminus hydro-
phobic domain (rBcl-2) were expressed in the pET23d vector in
Escherichia coli and puri¢ed as previously described [11,23^25].
Flag-tagged BimL was expressed as a glutathione S-transferase
(GST) fusion protein in the pGEX-2T vector in E. coli. The GST-
Flag-BimL fusion proteins were recovered in the soluble bacteria
fraction and were bound to glutathione-Sepharose. Flag-BimL was
released by thrombin cleavage (100 U; 12 h) and further puri¢ed by
chromatography on Q-Sepharose followed by Mono Q-Sepharose (see
Fig. 2).
The puri¢ed proteins which were s 95% pure were stored in 25 mM
Tris^HCl, 0.1 mM dithiothreitol (DTT), 30% glycerol, pH 7.5, at
380‡C.
2.4. Cell cultures and isolation of mitochondria
HeLa cells were grown at 37‡C in 5% CO2, in RPMI 1640 medium
(Gibco, BRL), supplemented with antibiotics, glutamine and 10%
fetal bovine serum.
Mitochondria were isolated from HeLa cells as previously described
[11,26]. In brief, HeLa cells were harvested in isotonic mitochondrial
bu¡er (MB) (210 mM mannitol, 70 mM sucrose, 1 mM EDTA,
10 mM HEPES (pH 7.5)) supplemented with complete protease in-
hibitor cocktail (Boehringer Mannheim). The cells were broken by six
passages through a 25G1 0.5- by 25-mm needle ¢tted on a 5-ml
syringe, and the suspension was centrifuged at 2000Ug in an Eppen-
dorf centrifuge at 4‡C. This procedure was repeated twice, and super-
natants from each step were pooled before being subjected to centri-
fugation at 13 000Ug at 4‡C for 10 min. The supernatant was further
centrifuged at 100 000Ug for 10 min at 4‡C to yield the light mem-
brane pellet (not analyzed) and the ¢nal soluble fraction (S100). The
heavy membrane material was pooled and resuspended in MB-EGTA
(MB with 0.5 mM EGTA instead of EDTA) and centrifuged at
500Ug for 3 min at 4‡C to eliminate residual nuclei. The resulting
supernatant was centrifuged at 13 000Ug for 10 min at 4‡C to further
purify the mitochondrial fraction. Protein concentration was esti-
mated by the method of Bradford [27] with bovine serum albumin
as the standard.
2.5. In vitro assay for Bax insertion and cytochrome c release
Mitochondria were incubated in the presence or absence of various
recombinant proteins in 200 Wl of KCl bu¡er (125 mM KCl, 4 mM
MgCl2, 5 mM NaHPO4, 5 mM succinate, 0.5 mM EGTA, 15 mM
HEPES-KOH, pH 7.4, 5 WM rotenone) for 15 min at 30‡C and then
centrifuged for 5 min at 13 000Ug and 4‡C. The supernatants and the
pellets were used for the determination of cytochrome c release and
were separated by sodium dodecyl sulfate^polyacrylamide gel electro-
phoresis. For alkali extraction, the mitochondrial pellets were resus-
pended (1 mg of protein/ml) in freshly prepared 0.1 M Na2CO3 (pH
11.5) and incubated for 20 min on ice. The membranes were then
pelleted by centrifugation (100 000Ug for 20 min at 4‡C). Mitochon-
drial membrane pellets corresponding to supernatants were separated
by sodium dodecyl sulfate^polyacrylamide gel electrophoresis.
2.6. Gel ¢ltration analysis
Gel ¢ltration was performed at 4‡C on a Superdex 200 (16/60)
column (Amersham Pharmacia Biotech) equilibrated in 25 mM
HEPES-NaOH, 300 mM NaCl, 0.2 mM DTT, 2% (w/v) CHAPS,
pH 7.5, and run at a £ow rate of 1 ml/min. The column was calibrated
with gel ¢ltration standard proteins from Amersham Pharmacia Bio-
tech giving the following elution volumes: thyroglobulin (669 000 Da),
49.9 ml; ferritin (440 000 Da), 55.9 ml; catalase (232 000 Da), 65.5 ml;
BSA (67 000 Da), 77.5 ml; ovalbumin (43 000 Da), 83.2 ml; chymo-
trypsinogen A (25 000 Da), 92.9 ml; ribonuclease A (13 700 Da),
97.4 ml. A 500-Wl sample was loaded onto the column, and the eluate
was monitored at 280 nm. After 20 min elution (20 ml), fractions of
2 ml were collected, and aliquots from the fractions were analyzed by
Western blotting. The proteins were detected with the speci¢c anti-
bodies as indicated in the ¢gures.
3. Results
3.1. Bim induces cytochrome c release of mitochondria in
cultured HeLa cells
During apoptosis induced by overexpression of Bid, Bax
undergoes a conformational change resulting in unmasking
of the NH2-terminal domain (5 and unpublished data). This
change of Bax immunoreactivity, toward NH2-terminal anti-
bodies, allowed us to assess in vivo the activation of endoge-
nous Bax by Bim. HeLa cells were transfected with pCI-His-
BimL vector in the presence of 100 WM caspase inhibitor
Z-VAD-fmk and localization of proteins was performed by
microscopy (Fig. 1). Bim positive cells displayed a mitochon-
drial staining, clearly evidenced by co-localization with mt-
hsp-70 (Fig. 1A-C). This is in agreement with the ¢nding
that Bim is associated with isolated mitochondria during ap-
optosis [20]. We also found cells in which Bim was clearly
cytosolic. With an antibody raised against amino acids 1^21
of Bax, no staining was observed in non-transfected cells. In
contrast, Bim overexpressing cells displayed a punctate Bax
staining characteristic of Bax activation (Fig. 1D^F). In addi-
tion, double immunostaining revealed that Bim positive cells
exhibited a di¡used cytosolic pattern of cytochrome c (Fig.
1G^I). All Bim-transfected cells containing cytochrome c-de-
pleted mitochondria displayed Bax immunoreactivity. Because
cells had been cultured with the caspase inhibitor Z-VAD-
fmk, no nuclear fragmentation was observed in Bim positive
cells. In contrast, in the absence of Z-VAD-fmk, cells under-
went caspase activation and died (data not shown). Taken
together, these experiments show that overexpression of Bim
in cells leads to Bax activation, cytochrome c release and ap-
optosis.
3.2. Puri¢cation of LC8-free recombinant BimL
In an attempt to study the direct e¡ect of Bim and Bid on
isolated mitochondria, we puri¢ed to homogeneity recombi-
nant Flag-BimL (rBimL) (Fig. 2A, see Section 2). Protein im-
munoblotting with speci¢c anti-Bim antibodies detected a
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single 18-kDa band (data not shown). Gel ¢ltration analysis
of the recombinant protein in 2% CHAPS extraction bu¡er
showed that rBimL was eluted in the low molecular weight
fractions corresponding to a relative molecular weight of 20^
25 kDa (Fig. 2B, fractions 36^38), and indicating that it was
puri¢ed as a monomer.
3.3. In contrast to Bid, Bim neither induces Bax insertion in
OMM nor induces cytochrome c release from isolated
mitochondria
Bid-induced insertion/oligomerization of Bax in the OMM
is induced before the release of cytochrome c [12]. To assess
whether the release of cytochrome c induced by Bim in cells
was a direct e¡ect of Bim on mitochondria, we tested whether
addition of rBimL to mitochondria was able to induce Bax
insertion and cytochrome c release. As shown in Fig. 3, we
assessed Bax insertion into the outer membrane with alkali
extraction of freshly isolated mitochondria from HeLa cells,
which contain loosely associated Bax [11,12]. As expected,
Fig. 2. Analysis of Bim recombinant protein on a Coomassie-stained
gel. A: Coomassie gel of GST-Flag-tagged BimL proteins (45 kDa)
recovered in the soluble bacteria fraction, treated with thrombin
(100 U, 12 h). 1: glutathione column; 2: thrombin elution; 3:
rBimL (1 Wg) from Q- and Mono Q-Sepharose chromatography pu-
ri¢cation. Arrow indicates Flag-tagged BimL (rBimL) (18 kDa).
Note the elimination of the shorter contaminating elements (*) after
elution. B: Analysis of puri¢ed rBimL in 2% CHAPS extraction
bu¡er by gel ¢ltration on Superdex 200. Fractions of 2 ml were col-
lected and every second fraction was analyzed by Western blotting
using the rabbit polyclonal anti-Bim antibody.
Fig. 1. Bax and cytochrome c immunostaining in Bim expressing cells. HeLa cells were transfected with a BimL expression vector, in the pres-
ence of 100 WM Z-VAD-fmk, and were immunostained for Bax, cytochrome c, Bim and mt-hsp-70, 24 h later. A^C: Bim and mt-hsp-70;
D^F: Bim and Bax; G^I: Bim and cytochrome c. Nuclei were visualized by Hoechst 33258 staining.
Fig. 3. Insertion of Bax in mitochondrial membranes. A: Mitochon-
dria were isolated from HeLa cells, incubated with 5 nM of tBid or
0.5 WM of BimL and treated with alkali (0.1 M Na2CO3 pH 11.5).
Mitochondrial pellets were analyzed by Western blotting for the
presence of Bax. Voltage-dependent anion channel protein, inserted
into mitochondrial membranes, was used as a gel-loading control.
B: Cytochrome c was analyzed by Western blotting in the mito-
chondrial suspension following incubation with either Bid or Bim.
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addition of 5 nM rtBid to the mitochondria induced Bax
insertion in the OMM. Consequently, Bax levels decrease in
the supernatant fraction (Fig. 3A). In clear contrast, when
mitochondria were incubated with BimL, even at a concentra-
tion up to 1 WM, Bax was not inserted. We next checked the
release of cytochrome c (Fig. 3B). Addition of 5 nM rtBid
released cytochrome c whereas 1 WM rBimL had no e¡ect.
Thus, these data showed that Bim, unlike Bid, cannot induce
endogenous Bax insertion in the OMM, and cannot release
cytochrome c from isolated mitochondria.
3.4. Unlike Bid, Bim does not trigger release of cytochrome c
but overcomes Bcl-2 inhibition of Bid-induced cytochrome c
release in vitro
Recombinant tBid and BimL were then tested for their abil-
ity to trigger the release of cytochrome c in the presence of
recombinant anti-apoptotic proteins (Fig. 4). Whereas 5 nM
tBid was able to trigger the release of cytochrome c from
mitochondria, Bim, even at a concentration of 1 WM, had
no e¡ect (Fig. 4A). The cytochrome c release induced by
5 nM rtBid was partially inhibited by 0.1 WM rBcl-xL (lane
4) whereas a complete inhibition was obtained with 1 WM
rBcl-xL (lane 5). Equivalent results were obtained when we
used rBcl-2 instead of rBcl-xL (Fig. 4B). Because Bim has
previously been shown to bind to anti-apoptotic Bcl-2
([17,18] and our unpublished results), we tested whether
rBimL could counteract the rBcl-2 or rBcl-xL e¡ect. Addition
of 1 WM rBimL overcame the inhibitory e¡ect obtained with
0.1 WM rBcl-xL on rtBid-induced cytochrome c release (lane
6). However, addition of 1 WM rBimL appeared insu⁄cient to
block the protective e¡ect conferred by 1 WM rBcl-xL (lane 7).
Similar results were obtained when rBcl-x was replaced by
rBcl-2 (Fig. 4B). As for Bcl-xL, addition of an equimolar
concentration of rBimL to rBcl-2 was insu⁄cient to inhibit
rBcl-2 control over rtBid-induced cytochrome c release. How-
ever, an excess of rBim over rBcl-2 abrogated rBcl-2 inhibition
of cytochrome c release. Together, these results demonstrate
that Bim does not release directly cytochrome c, but is able
to facilitate rtBid-induced cytochrome c release by blocking
rBcl-2 and/or rBcl-xL and probably by inhibiting endogenous
Bcl-x inserted in the OMM of mitochondria [12,28].
4. Discussion
We have previously shown that recombinant tBid e⁄ciently
renders the OMM permeable to cytochrome c [12]. This po-
tent pro-apoptotic BH3-containing fragment, produced by
caspase cleavage of Bid, probably acts by directly activating
Bax [11] or Bak [9]. In favor of this hypothesis, tBid interacts
directly with either protein in yeast two-hybrid or in co-im-
munoprecipitation experiments [9,29]. The addition of Bid to
mitochondria was also found to trigger insertion and oligome-
rization of both Bax [12] and Bak [9]. Furthermore, Bax and
Bak are essential for the release of cytochrome c induced by
tBid [30].
In contrast to Bid, addition of another BH3-only protein
BimL, even at a 200-fold higher concentration, did not cause
cytochrome c release from isolated mitochondria, or directly
trigger the membrane insertion and oligomerization of Bax
Fig. 4. BimL counters the inhibition of Bid-induced cytochrome c
release by Bcl-xL or Bcl-2. Mitochondria from HeLa cells were iso-
lated and incubated with 5 nM of tBid or 1 WM of BimL in the
presence of Bcl-xL. A: Cytochrome c levels in mitochondrial pellets
were analyzed by Western blot. Mt-hsp-70 was used as loading con-
trol. The counteracting e¡ect of Bim on Bcl-xL protection against
Bid-induced cytochrome c release is clearly apparent when compar-
ing lane 6 with lane 4. B: Bim inhibits Bcl-2 in a dose-dependent
manner. Mitochondria were incubated with 5 nM of tBid, 1 WM of
BimL and 0.1^1 WM of Bcl-2. Cytochrome c levels were determined
by Western blot in both the pellet and in the supernatant. Data
shown in A and B are representative of three di¡erent experiments.
Fig. 5. Two classes of BH3-only proteins. This model proposes two
classes of BH3-only proteins: those, like tBid, that trigger apoptosis
through direct activation of Bax or Bak and others such as Bim
that contribute to apoptosis through inhibition of the anti-apoptotic
activity of Bcl-2, Bcl-xL and other anti-apoptotic members of this
family. Apoptosis only occurs if Bcl-2-like anti-apoptotic proteins
are inhibited by Bim-like proteins and if at the same time Bax-like
proteins are activated by Bid-like proteins.
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(Fig. 3 and data not shown). The failure of Bim to activate
Bax directly probably re£ects its inability to interact with Bax
since none of the Bim isoforms binds Bax (or Bak) in yeast
two-hybrid or in co-immunoprecipitation experiments ([17,18]
and data not shown). By contrast, the killing activity of Bid
appears to be closely coupled to its ability to bind Bax since
those mutations in its BH3 domain a¡ecting Bax binding also
abrogated biological activity [11,29].
Although rBimL cannot activate Bax/Bak directly, it can, in
a dose-dependent manner, antagonize the ability of rBcl-2 or
rBcl-xL to block tBid-induced cytochrome c release from pu-
ri¢ed mitochondria (Fig. 4) [12,31,32]. The mutual neutraliza-
tion of Bim by Bcl-2 is re£ected in the recent data reporting
that the cellular attrition caused by Bcl-2 de¢ciency can be
prevented in mice lacking both Bim and Bcl-2 [33]. However,
a complete inhibition was only observed when BimL was in
excess to rBcl-2/rBcl-xL. If we assume that one molecule of
Bid interacts with one molecule of Bcl-2 or Bcl-xL then it is
unclear why an excess of BimL is required to restore rtBid-
induced cytochrome c. This may re£ect higher a⁄nity of Bcl-2
(or Bcl-xL) for Bid than for Bim, or that, to be fully active,
Bim requires post-translational modi¢cations such as phos-
phorylations [19], which are not present in the recombinant
Bim protein. Even though rBimL can antagonize rBcl-xL, its
addition did not appear su⁄cient to trigger the release of
cytochrome c from mitochondria isolated from HeLa cells
[12]. This appears inconsistent with the observation that
BimL overexpression in HeLa cells was cytotoxic and caused
signi¢cant mitochondrial damage (Fig. 1). These data suggest
that overexpression of Bim in cells generates an unknown
signal that leads to activation of Bax-like proteins. It is rea-
sonable to think that BH3-only proteins able to interact di-
rectly with Bax, as for example Bid, could represent such a
signal. Though the anti-apoptotic proteins such as Bcl-2 or
Bcl-xL may sequester and thereby inhibit BH3-only proteins
such as Bim [34], they may also act to directly inhibit Bax or
Bak. Indeed, we have previously shown that a mutant of Bcl-
xL that cannot interact with Bax or Bak but interacts with Bid
was less e⁄cient in blocking Bax activation and cytochrome c
release [12]. In such a scenario, binding of Bim may release
Bax/Bak from inhibition by Bcl-2/Bcl-xL thereby allowing
Bax/Bak to be activated by a second class of BH3-only pro-
teins, like Bid.
In conclusion, we have shown that two BH3-only proteins
of the Bcl-2 family, namely Bid and Bim, act predominantly
through di¡erent mechanisms. Bid probably triggers apoptosis
by directly activating Bax/Bak, whereas Bim sensitizes cells to
apoptosis by inhibiting Bcl-2, Bcl-xL and other anti-apoptotic
members of this family (Fig. 5). Depending on their ability to
interact with either anti-apoptotic proteins (Bcl-2, Bcl-xL) or
with pro-apoptotic proteins such as Bax or Bak, BH3-only
proteins fall into functionally distinct subclasses that act at
di¡erent steps during cell death signaling. Following a death
stimulus, apoptosis would occur if anti-apoptotic proteins of
the Bcl-2 family are inhibited by Bim-like proteins and at the
same time Bax-like proteins (Bax, Bak and Bok) are activated
by Bid-like proteins (for a model see Fig. 5).
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